Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLOFARABINE for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where CLOFARABINE was used for Neoplasm malignant.

Most Reported Side Effects for CLOFARABINE

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 201 14.2% 57 85
Off label use 158 11.1% 78 39
Drug ineffective 139 9.8% 43 33
Pyrexia 139 9.8% 25 50
Mucosal inflammation 89 6.3% 13 5
Sepsis 85 6.0% 46 24
Alanine aminotransferase increased 82 5.8% 14 18
Acute kidney injury 80 5.6% 54 20
Multiple organ dysfunction syndrome 77 5.4% 72 25
Aspartate aminotransferase increased 76 5.4% 13 15
Neutropenia 76 5.4% 24 19
Pancytopenia 69 4.9% 27 23
Haematotoxicity 67 4.7% 10 1
Product use in unapproved indication 66 4.7% 23 16
Bone marrow failure 63 4.4% 37 13

Other Indications for CLOFARABINE

Acute myeloid leukaemia (357) Acute lymphocytic leukaemia (323) Bone marrow conditioning regimen (160) Acute lymphocytic leukaemia recurrent (71) Chemotherapy (48) Product used for unknown indication (43) Langerhans' cell histiocytosis (37) B precursor type acute leukaemia (35) Allogenic stem cell transplantation (31) Stem cell transplant (26)

Other Drugs Used for Neoplasm malignant

PALBOCICLIB (1,996) CAPECITABINE (1,493) PEMBROLIZUMAB (1,135) PACLITAXEL (984) CARBOPLATIN (977) NIVOLUMAB (947) OXALIPLATIN (823) PAZOPANIB (716) CYCLOPHOSPHAMIDE (685) FLUOROURACIL (676)

Related Pages

CLOFARABINE Full Profile All Neoplasm malignant Drugs CLOFARABINE Demographics CLOFARABINE Timeline